GlassScriptPhysician profile
Don Arthur Enty
NPI 1215914924
$3,018.35
in general payments reported to CMS, 2019-2025
24 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $240 · 2021: $810 · 2022: $154 · 2023: $353 · 2024: $508 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $896.90 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $753.97 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Na |
| Si-Bone, INC. | $220.65 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $195.30 | 2019-2024 | Ajovy |
| Vertos Medical, INC. | $133.74 | 2023-2024 | Mild Device Kit |
| Medtronic, INC. | $133.50 | 2022-2024 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $111.28 | 2021-2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $79.44 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $54.73 | 2023-2025 | Xtampza |
| Medtronic USA, INC. | $52.65 | 2020 | |
| Biotronik Nro, INC. | $49.12 | 2025 | Prospera |
| Nalu Medical, INC. | $42.81 | 2021 | |
| Abbvie INC. | $39.70 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.44 | 2019-2024 | Relistor |
| Relievant Medsystems, INC. | $34.71 | 2020-2023 | Intracept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $33.56 | 2019 | |
| Mml US, INC. | $23.66 | 2023 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $22.84 | 2024 | |
| Spr Therapeutics, INC | $21.91 | 2024 | Sprint Pns System |
| Vertiflex, INC. | $21.50 | 2019 | |
| Horizon Therapeutics Plc | $17.51 | 2022 | |
| Assertio Therapeutics, INC. | $15.08 | 2019 | |
| Protega Pharmaceutials INC | $14.75 | 2023 | Roxybond |
| Stimwave Technologies Incorporated | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Enty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.